Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adults 56 years of age and older: a Phase II randomized study

.

Source: Human Vaccines and Immunotherapeutics - March 31, 2020 Category: Allergy & Immunology Authors: Judith Kirstein Miriam Pina Judy Pan Emilia Jordanov Mandeep S. Dhingra Source Type: research